EPO can block apoptotic injury through the maintenance of mitochondrial membrane potential and the inhibition of caspase activity during cardiovascular injury, renal disease, metabolic injury, and neurodegeneration [20, 22, 23, 28, 78-80]. Here, EPO is linked to kidney disorder.